por
Kaprio, Tuomas,
Fermér, Christian,
Hagström, Jaana,
Mustonen, Harri,
Böckelman, Camilla,
Nilsson, Olle,
Haglund, Caj
Publicado 2014
“…The aim of this study was to investigate the role of PODXL in CRC by use of a novel monoclonal antibody. METHODS: In
1983–2001, 840 consecutive colorectal cancer patients were treated at
Helsinki University Central Hospital, of whom 767 were successfully scored for PODXL immunohistochemical expression from tumour tissue microarrays by use of a novel monoclonal in-house antibody. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto